Financial News
Faron Pharmaceuticals CMO "looking forward to a year filled with good data for the patients"
February 16, 2023 at 07:10 AM EST
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief medical officer Marie-Louise Fjällskog updates Proactive's Thomas Warner the clinical-stage biopharmaceutical company's wholly-owned precision immunotherapy asset, Bexmarilimab.
Fjällskog says that she's "looking forward to a year filled with good data for the patients."
Contact Details
Proactive UK Ltd
Proactive UK Ltd
+44 20 7989 0813
More News
View More
Meta Platforms Stock Falls Despite Strong Growth—Here’s Why
Today 11:34 EDT
Cameco's $80 Billion U.S. Nuclear Deal Changes Everything
Today 9:16 EDT
NU Stock: U.S. Bank License May Be the Next Growth Catalyst
Today 8:06 EDT
5 Stocks to Stuff Your Portfolio This November
Today 7:16 EDT
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
